Followers

Saturday, September 19, 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j

No comments:

Post a Comment

Report: 93% Indian executives see rise in cyber budget next year

from Business News: Business News, Business News Today, Latest Business News, Stock Markets, Financial News, India Business & World Bu...